Replies to post #75176 on PharmaCyte Biotech Inc (PMCB)

[SirCharChar]

Triple9, do you see PMCB eventually being bought out in a few years if trial results are good? I can't imagine them going through alone. I would see a buyout price of $2-$4 per share.

Your thoughts? Thanks!

[tulla236a]

It's still mind boggling to me that the pps is in the pennies. Ciab will be approved for many uses and Pmcb has rights to all at different percent levels.

It's going to be BIG!!!

[rudygerner]

Excellent DD Trip, like always.

At this point we can only guess which route PharmaCyte will take, partnership or buyout, but recent events combined with social media postings have me thinking a buyout is going to happen, pending positive trial data, of course.

A positive outcome in the upcoming clinical trial in LAPC will serve to permanently validate the Cell-in-a-Box® platform technology, thereby making the Cell-in-a-Box®/Melligen cell combo to treat diabetes that much more valuable. (For years I've been searching for a diabetes treatment which can equal PharmaCyte's both in terms of simplicity (no device required) and efficiency - to my knowledge an equal treatment doesn't exist in the clinic or on the market.)

A positive outcome in the upcoming trial will also serve to rid this mb of the naysayers who stupendously waste their time and effort to doubt the intentions and capabilities of this company and this technology.

Soon as IND gets filed we're off and running, I'm still adding once every week right up until IND is filed. I haven't traded or sold one share and I don't intend to until diabetes is in the clinic or a buyout.

IND is coming.